Valori takes first step in buy-and-build strategy with acquisition of Omnext
Utrecht/Veenendaal/Amsterdam, 8th of July 2021 – Valori takes a majority stake in Omnext, a leading international player in software code analysis. The joining of forces, made possible by Holland Capital, creates a unique end-to-end quality solution for customers.
Own platform for software code analysis
Continuous quality control of software development is crucial for successful digital transformation. Whether it concerns reducing technical debt, increasing development speed, or reducing costs. Omnext has been specialized in software code analysis for 20 years, and developed its own software analysis platform: Omnext Fit Test. This platform offers developers and IT managers real-time independent and objective insight into the quality and technical risks of their applications. Omnext Fit Test supports over 40 different technologies including low-code platforms OutSystems and Mendix.
Unique end-to-end quality solution
With the combination of software code analysis from Omnext and Valori as the independent number 1 in QA & Testing, a unique end-to-end quality solution is created for customers.
Jaap Merkus, CEO of Valori, sees Omnext’s low-code analysis capability as the key to unique added value for customers. “Low-code platforms give organizations a substantial advantage in terms of development speed. Unfortunately, in practice we often see the downside of this speed. Due to the speed of development, quality is lost sight of, and technical debt is unintentionally built up. Omnext’s unique proposition fits in perfectly with Valori’s ambition to support customers with the incorporation of quality into low-code development processes and in this way to fulfil the promise of low-code. Omnext therefore complements our Building IT Quality vision”.
Jaco de Vries, CEO of Omnext, agrees that the speed at which software is built today, and with it the amount of software that is being used, has made unprecedented leaps. “With the arrival of low-code platforms such as OutSystems and Mendix, the amount of software that is being realized and the speed at which this is happening has increased to unprecedented levels. Because organizations are increasingly dependent on low-code applications, their technical and functional quality has become an important item on the CIO’s agenda. The Omnext-Valori combination offers us the opportunity to make Software Quality Assurance for our customers more complete and their software even more future-proof.”
Holland Capital has been involved in Valori as a shareholder since 2019. She actively supports management in the strategic development of the company. Ewout Prins, managing partner Holland Capital, about the transaction: “With its many years of expertise and driven team, Omnext is a valuable acquisition in Valori’s buy-and-build strategy. We see many substantive synergies for both companies.”
Valori, founded in 1989 and based in Utrecht, is the largest independent software testing and quality assurance player in the Netherlands. Valori tests new computer systems or modifications to existing systems. With 200 specialized professionals, she has knowledge of a large number of sectors, tooling, and software platforms. Valori supports its customers with architecture, functional management, business analysis and the testing and monitoring of software implementations. www.valori.nl
Since 2001, Omnext has been helping organizations to keep grip on their application landscape. Omnext developed its own software analysis platform for this: Omnext Fit Test. This allows organizations to manage risks and increase the quality of their software. The platform automatically analyses the source code and benchmarks it against industry best practices and the ISO-25010 software quality guideline. This allows customers to automatically monitor the technical condition of applications. Omnext, like Valori, is a recognized OutSystems Technology Alliance Partner. In addition, it also focuses on other low-code platforms such as Mendix, Microsoft Power Apps, PEGA and BettyBlocks. www.omnext.com
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets. www.hollandcapital.nl